Trueblue, Inc. (TBI) is a publicly traded Industrials sector company. As of May 21, 2026, TBI trades at $5.44 with a market cap of $169.65M and a P/E ratio of -3.07. TBI moved +1.58% today. Year to date, TBI is +15.25%; over the trailing twelve months it is -3.55%. Its 52-week range spans $3.18 to $9.05. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces TBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes TBI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $5.44 |
| Market Cap | $169.65M |
| P/E Ratio | -3.07 |
| EPS | $-1.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.05 |
| 52-Week Low | $3.18 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.64B |
| Net Income | $-53.41M |
| Gross Margin | 21.93% |
1 analysts cover TBI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.